SHINE's final SER for Wisconsin facility issued by NRC

March 1, 2023, 12:00PMNuclear News
SHINE’s isotope production building, called the Chrysalis, under construction in October 2022. (Photo: SHINE)

The Nuclear Regulatory Commission has issued its final safety evaluation report (SER) related to the operating license application for SHINE Technologies' large-scale medical isotope production facility, known as The Chrysalis, in Janesville, Wis. The SER documents the results of NRC staff’s technical and safety review of SHINE’s application. SHINE announced the NRC’s decision on February 27.

A record of decision concerning the proposed issuance of the operating license will be published by the NRC at a future date.

To continue reading, log in or create a free account!

Related Articles

On moving fast and breaking things

March 16, 2026, 9:33AMNuclear NewsCraig Piercy

So much of what is happening in federal nuclear policy these days seems driven by a common approach popularized in the technology sector. Silicon Valley calls it “move fast and break...

Aalo Atomics discusses the road ahead

March 12, 2026, 1:13PMNuclear News

Yasir Arafat, president and chief technology officer of Aalo Atomics, participated in the first day of sessions at the Nuclear Regulatory Commission’s annual Regulatory Information...